Nikko Asset Management Americas’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-504,201
Closed -$37.7M 229
2021
Q1
$37.7M Buy
504,201
+66,002
+15% +$4.94M 0.18% 88
2020
Q4
$47.5M Buy
438,199
+19,964
+5% +$2.17M 0.27% 76
2020
Q3
$36.3M Sell
418,235
-53,124
-11% -$4.61M 0.32% 64
2020
Q2
$38.9M Sell
471,359
-21,162
-4% -$1.75M 0.51% 50
2020
Q1
$29.2M Sell
492,521
-4,945
-1% -$293K 0.54% 49
2019
Q4
$34.4M Buy
497,466
+34,089
+7% +$2.36M 0.54% 52
2019
Q3
$48.1M Buy
463,377
+164,601
+55% +$17.1M 0.85% 38
2019
Q2
$27.7M Buy
298,776
+230,328
+337% +$21.3M 0.54% 48
2019
Q1
$6.26M Buy
68,448
+68,246
+33,785% +$6.24M 0.17% 96
2018
Q4
$11K Sell
202
-3
-1% -$163 ﹤0.01% 145
2018
Q3
$25K Buy
+205
New +$25K ﹤0.01% 144